Wednesday, April 26, 2023
4:00 – 5:00 pm
Regulatory Check In: A Discussion of the FDA Process, Market Access and Regulatory Issues of Concern When Entering and Doing Business in the US Market
Vernessa Pollard, Partner, McDermott Will and Emery | Angus McQuilken, Industry Relationship Executive – Life Sciences, McDermott Will and Emery
Navigating the evolving regulatory landscape has become a pain point for companies. What are the business repercussions of new regulatory and reimbursement initiatives? This session will address the specific impacts of new regulations and give market access updates on business strategies, partnerships, and investment. Learn from experts on the recent guidelines that affect the Asian markets and what impact this will have on your business.
Thursday, April 27, 2023
3:00 – 4:00 pm
Deals, Breakthrough Innovation, And Partnering For Biotech’s Next Generation
Siddhartha Sivaramakrishnan, Partner, McDermott Will and Emery (Moderator) | Kathy He, CEO, Cargene (Panelist) | Kevin Huh, CEO, Korea Innovative Medicines Consortium (Panelist)
What does biopharma look like in the Asian market in 2023 and beyond? With recent reaction to market changes, learn from leading investors for their insights on emerging areas of innovation and how this impacts the future of development.
